5.0

Table Of Contents
Mailing a Copy of a Story
100
Audio: 0:42
Backtime: 17:35:23
Date: 10/4/14 14:41:46
Mod by: dm58
WR: dm58
App.: dm58
Cumetime: 0:04:07
_______________________________________________________________
<<< ON CAM >>>
((ON CAM))
PROMISING RESEARCH RESULTS INDICATE A NEW PILL CALLED "TRACLEER" COULD
TRANSFORM THE TREATMENT OF PULMONARY HYPERTENSION, A RELATIVELY RARE BUT
POTENTIALLY FATAL LUNG DISORDER.
<<< TAKE VO >>>
((TAKE VO))
<<< *CG 2LINE
PULMONARY HYPERTENSION
NEW TREATMENT >>>
THE ONLY TREATMENT CURRENTLY AVAILABLE HAS TO BE CONSTANTLY INFUSED INTO
THE BLOOD VIA A PERMANENT TUBE IN A VEIN IN THE NECK OR CHEST THAT IS
ATTACHED TO A PUMP STRAPPED TO THE BODY.
IN THIS WEEK’S ISSUE OF THE LANCET MEDICAL JOURNAL, SCIENTISTS DESCRIBE
HOW PATIENTS WHO TOOK "TRACLEER" HAD DRAMATIC IMPROVEMENTS IN THEIR
BLOOD TESTS, THEIR EXERCISE CAPACITY AND THEIR ABILITY TO DO EVERYDAY
TASKS WITHOUT SHORTNESS OF BREATH.
"TRACLEER" IS IN THE FINAL STAGES OF APPROVAL BY THE FOOD AND DRUG
ADMINISTRATION AND SHOULD BE AVAILABLE IN THE UNITED STATES IN A FEW
MONTHS. EUROPEAN APPROVAL IS EXPECTED NEXT YEAR.